Trial ID
AT148006
Sponsor ID
ASPEN-06
A PHASE 2/3 STUDY OF ALX148 IN PATIENTS WITH ADVANCED HER2-OVEREXPRESSING GASTRIC/GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA (ASPEN-06)
Principal Investigator
Samuel Lee, MD
3 Locations
Locations
Arlington Office
Fairfax Office
Gainesville Office
Learn More About This Trial
Other Relevant Trials
Trial ID
SGN-PDL1V
Sponsor ID
SGNPDL1V-001
A Phase 1 Study of SGN-PDL1V in Advanced Solid Tumors
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
Trial ID
MCLA-129
Sponsor ID
MCLA-129-CL01
Phase 1/2 Dose Escalation and Expansion Study Evaluating MCLA-129, a Human Anti-EGFR and Anti-c-MET Bispecific Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
